Lv31
340 积分 2023-10-20 加入
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
8天前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
9天前
已完结
Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis
1个月前
已关闭
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study
1个月前
已完结
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
1个月前
已完结
Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis with Baricitinib, Abatacept, Vedolizumab, and Reduced-Dose Post-Transplantation Cyclophosphamide in Pediatric Acute Leukemia: A Prospective Study
8天前
已采纳
Risk Factors and Predictive Model for Postoperative High Myopia in Children Undergoing Congenital Cataract Surgery With Intraocular Lens Implantation
1个月前
已采纳
Risk Factors and Predictive Model for Postoperative High Myopia in Children Undergoing Congenital Cataract Surgery With Intraocular Lens Implantation
1个月前
已采纳
StomataCounter: a neural network for automatic stomata identification and counting
1个月前
已采纳
The evolution of hematopoietic models through a clonal lens
1个月前
已采纳
Use of Doppler Ultrasonic Flowmeter for Angiography
1个月前
已撤回
Liberalized Diets During Neutropenia: Ongoing Uncertainty in Hematopoietic Stem-Cell Transplantation
1个月前
已采纳
皖公网安备34019202002308
